Moseley Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
8,134
+21
+0.3% +$3.9K 0.52% 48
2025
Q1
$1.7M Buy
8,113
+230
+3% +$48.2K 0.66% 40
2024
Q4
$1.4M Buy
7,883
+120
+2% +$21.3K 0.55% 45
2024
Q3
$1.53M Buy
7,763
+122
+2% +$24.1K 0.61% 41
2024
Q2
$1.31M Buy
7,641
+68
+0.9% +$11.7K 0.61% 42
2024
Q1
$1.38M Buy
7,573
+71
+0.9% +$12.9K 0.68% 39
2023
Q4
$1.16M Sell
7,502
-4,547
-38% -$705K 0.65% 39
2023
Q3
$1.8M Sell
12,049
-147
-1% -$21.9K 1.07% 22
2023
Q2
$1.64M Buy
12,196
+843
+7% +$114K 0.96% 25
2023
Q1
$1.81M Buy
11,353
+310
+3% +$49.4K 1.17% 22
2022
Q4
$1.78M Sell
11,043
-46
-0.4% -$7.43K 1.28% 24
2022
Q3
$1.49M Buy
11,089
+934
+9% +$125K 1.09% 23
2022
Q2
$1.56M Buy
10,155
+328
+3% +$50.2K 1.09% 25
2022
Q1
$1.59M Sell
9,827
-280
-3% -$45.4K 0.86% 34
2021
Q4
$1.37M Buy
10,107
+106
+1% +$14.3K 0.62% 51
2021
Q3
$1.09M Buy
10,001
+614
+7% +$67K 0.55% 60
2021
Q2
$1.06M Buy
9,387
+570
+6% +$64.2K 0.52% 60
2021
Q1
$954K Sell
8,817
-15
-0.2% -$1.62K 0.53% 56
2020
Q4
$946K Buy
8,832
+965
+12% +$103K 0.55% 56
2020
Q3
$689K Sell
7,867
-369
-4% -$32.3K 0.49% 58
2020
Q2
$809K Buy
8,236
+843
+11% +$82.8K 0.67% 41
2020
Q1
$563K Sell
7,393
-75
-1% -$5.71K 0.66% 48
2019
Q4
$661K Sell
7,468
-1,524
-17% -$135K 0.65% 52
2019
Q3
$681K Sell
8,992
-1,780
-17% -$135K 0.71% 47
2019
Q2
$783K Buy
10,772
+3,122
+41% +$227K 0.73% 44
2019
Q1
$617K Buy
+7,650
New +$617K 0.64% 48